Taurine and Adverse Events

• A randomized controlled trial of L-taurine for fatigue in decompensated cirrhosis.

  • 2026-04-24
  • RCT · n = 161
  • Hepatology communications 10(5)
  • • Swarup Sasidharan
    • Cyriac Abby Philips
    • Ajit Tharakan
    • Rizwan Ahamed
    • Tharun Tom Oommen
    • John Menachery
    • Rosh Varghese
    • Philip Augustine

  • PubMed: 42043864
  • DOI: 10.1097/hc9.0000000000000938

  3 Insights on

  • Adverse Events

  • High evidence
  • Large Human Trial

  Adverse events occurred in 11.8% of patients treated with taurine, all of which were mild.

  Effect

  Harmful

  Effect size

  Small

  Dose

  1000 mg/d